Old Web
English
Sign In
Acemap
>
authorDetail
>
Afton Katkov
Afton Katkov
Cardiff University
Valganciclovir
Medicine
EBV Positive
Epstein–Barr virus
Virology
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nanatinostat (Nstat) and Valganciclovir (VGCV) in Relapsed/Refractory (R/R) Epstein-Barr Virus-Positive (EBV + ) Lymphomas: Final Results from the Phase 1b/2 VT3996-201 Study
2021
Blood
Bradley M. Haverkos
Onder Alpdogan
Robert A. Baiocchi
Jonathan E. Brammer
Tatyana Feldman
Marcelo Capra
Elizabeth Brem
Santosh M. Nair
Phillip Scheinberg
Juliana Pereira
Leyla Shune
Erel Joffe
Afton Katkov
Robert McRae
Ivor Royston
Lisa Rojkjaer
Pierluigi Porcu
Show All
Source
Cite
Save
Citations (0)
Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results
2020
Blood
Pierluigi Porcu
Bradley M. Haverkos
Onder Alpdogan
Robert A. Baiocchi
Jonathan E. Brammer
Tatyana Feldman
Marcelo Capra
Elizabeth Brem
Phillip Scheinberg
Juliana Pereira
Leyla Shune
Afton Katkov
Robert McRae
Lisa Rojkjaer
Ivor Royston
Douglas V. Faller
Show All
Source
Cite
Save
Citations (0)
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study
2019
Blood
Pierluigi Porcu
Brad M. Haverkos
Onder Alpdogan
Marcelo Capra
Tatyana Feldman
Elizabeth Brem
Anusha Vallurupalli
Jonathan E. Brammer
Ana Fernandes Schriefer
Juliana Pereira
Anil Tulpule
Stefan K. Barta
Locke J Bryan
Richard Trauger
Sebastian Obrzut
John Gutheil
Afton Katkov
Robert McRae
Ivor Royston
Douglas V. Faller
Show All
Source
Cite
Save
Citations (0)
1